Taiwan FDA registration 14c31078614581efdfb13e993c85b372

"Aibo" ovulation (urine) test reagent (unsterilized)

TW: "艾博" 排卵(尿液)測試試劑 (未滅菌)
Taiwan flagTaiwan·Risk Class 1·ABON BIOPHARM (HANGZHOU) CO., LTD·Registered Nov 01, 2012 – Nov 01, 2022Cancelled
Registration details
Analysis ID
14c31078614581efdfb13e993c85b372
Customs Code
DHA04600177801
Company information
Manufacturer Country
China
Authorized Representative
Abbott Rapid Diagnostics Health Corp.
Product details
Intended Use
Limited to the first level identification range of the "luteinizing hormone test system (A.1485)" of the Measures for the Administration of Medical Equipment.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1485 Progesterone testing system
Import Information
Input;; Chinese goods
Dates and status
Registration Date
Nov 01, 2012
Expiry Date
Nov 01, 2022
Cancellation Date
Apr 12, 2024
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Aibo" ovulation (urine) test reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 14c31078614581efdfb13e993c85b372 and manufactured by ABON BIOPHARM (HANGZHOU) CO., LTD. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices